Fountain Pharmaceuticals (FPHI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Fountain Pharmaceuticals (FPHI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Fisner who wrote (26)	8/15/1997 12:45:00 AM
From: r. peter Dale	of 78

An interesting aspect of Fountain's encapsulation technology is an unexpected twist to this sort of drug delivery system. In general, it appears that when a drug is 'repackaged' in this particular way, this new 'formulation' can be considered a new 'drug'. Thus, pharmaceutical companies could use Fountain's products to, in effect, extend the patent life of a proprietary compound (not to mention market multiple 'formulations' of the same drug). Clearly a very lucrative market for Fountain; this would also easily explain Merck's interest. Best wishes, Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next